RUBELLA VIRUS - ANVISA Registration 10339840559

Access comprehensive regulatory information for RUBELLA VIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10339840559 and manufactured by DIASORIN ITALIA S.P.A.. The registration is held by DIASORIN LTDA with validity until Feb 10, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, ABBOTT IRELAND DIAGNOSTIC DIVISION, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.